AGI-14100
AGI-14100 is an orally bioavailable small molecule inhibitor of mutant IDH1, developed for research into acute myeloid leukemia (AML) . It has demonstrated activity in cellular assays and in vivo models, making it a tool for studying oncogenic metabolism and therapeutic strategies.
Product Specifications
CAS Number
1448346-43-7
Product Name Alternative
AGI14100, AGI-14100, AGI 14100, IDH1
Field of Research
Metabolism Research
Purity
99.91% (May vary between batches)
Solubility
DMSO:50 mg/mL (83.34 mM)
Smiles
N ([C@H] (C (NC1CC (F) (F) C1) =O) C2=C (Cl) C=CC=C2) (C (=O) [C@H]3N (C (=O) CC3) C4=CC (C#N) =CC=N4) C5=CC (F) =CC (F) =C5
Molecular Formula
C29H22ClF4N5O3
Molecular Weight
599.96
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC473219-100 1x 100 µL
Glycophorin A / CD235a (Erythrocyte Marker) (GYPA/3219R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
![Anti-Desmoglein 3 [AK23]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
